BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14698537)

  • 1. Serum VEGF and bFGF adds prognostic information in patients with normal platelet counts when sampled before, during and after treatment for locally advanced non-small cell lung cancer.
    Brattström D; Bergqvist M; Hesselius P; Larsson A; Wagenius G; Brodin O
    Lung Cancer; 2004 Jan; 43(1):55-62. PubMed ID: 14698537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumours and poorer survival in non-small cell lung cancer patients.
    Brattström D; Bergqvist M; Hesselius P; Larsson A; Lamberg K; Wernlund J; Brodin O; Wagenius G
    Lung Cancer; 2002 Jul; 37(1):57-63. PubMed ID: 12057868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma level and prognostic significance of VEGF, bFGF and MMP-9 in patients with advanced non-small-cell lung cancer].
    Zhao J; Liu XY; Zhang QY; Jiang W
    Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):676-9. PubMed ID: 16438890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.
    Bremnes RM; Camps C; Sirera R
    Lung Cancer; 2006 Feb; 51(2):143-58. PubMed ID: 16360975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients.
    Brattström D; Bergqvist M; Larsson A; Holmertz J; Hesselius P; Rosenberg L; Brodin O; Wagenius G
    Anticancer Res; 1998; 18(2A):1123-7. PubMed ID: 9615776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum semicarbazide-sensitive amine oxidase (SSAO) activity correlates with VEGF in non-small-cell lung cancer patients.
    Garpenstrand H; Bergqvist M; Brattström D; Larsson A; Oreland L; Hesselius P; Wagenius G
    Med Oncol; 2004; 21(3):241-50. PubMed ID: 15456951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.
    Iwasaki A; Kuwahara M; Yoshinaga Y; Shirakusa T
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):443-8. PubMed ID: 15019676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survival.
    Dudek AZ; Mahaseth H
    Cancer Invest; 2005; 23(3):193-200. PubMed ID: 15945504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor in the serum of patients with non-small cell lung cancer: correlation with platelet and leukocyte counts.
    Choi JH; Kim HC; Lim HY; Nam DK; Kim HS; Yi JW; Chun M; Oh YT; Kang S; Park KJ; Hwang SC; Lee YH; Hahn MH
    Lung Cancer; 2001; 33(2-3):171-9. PubMed ID: 11551412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor and basic fibroblast growth factor in patients with squamous cell oesophageal cancer.
    Wallner G; Ciechański A; Dabrowski A; Kozłowski M; Roliński J; Laudański J; Cwik G
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():122-3. PubMed ID: 11820569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer.
    Suwinski R; Giglok M; Galwas-Kliber K; Idasiak A; Jochymek B; Deja R; Maslyk B; Mrochem-Kwarciak J; Butkiewicz D
    BMC Cancer; 2019 May; 19(1):427. PubMed ID: 31068179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
    Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP
    J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide.
    Young RJ; Tin AW; Brown NJ; Jitlal M; Lee SM; Woll PJ
    Br J Cancer; 2012 Mar; 106(6):1153-9. PubMed ID: 22353811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.
    Salgado R; Vermeulen PB; Benoy I; Weytjens R; Huget P; Van Marck E; Dirix LY
    Br J Cancer; 1999 May; 80(5-6):892-7. PubMed ID: 10360671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of circulating cytokeratin fragments and angiogenic factors in NSCLC patients stage IIIa-IIIb receiving curatively intended treatment.
    Eriksson P; Brattström D; Hesselius P; Larsson A; Bergström S; Ekman S; Goike H; Wagenius G; Brodin O; Bergqvist M
    Neoplasma; 2006; 53(4):285-90. PubMed ID: 16830054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum levels of basic fibroblast growth factor in lung cancer patients: relevance to response of therapy and prognosis.
    Ueno K; Inoue Y; Kawaguchi T; Hosoe S; Kawahara M
    Lung Cancer; 2001; 31(2-3):213-9. PubMed ID: 11165400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.
    Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
    Cancer Invest; 2006 Oct; 24(6):576-80. PubMed ID: 16982461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer.
    Joensuu H; Anttonen A; Eriksson M; Mäkitaro R; Alfthan H; Kinnula V; Leppä S
    Cancer Res; 2002 Sep; 62(18):5210-7. PubMed ID: 12234986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients.
    Dirix LY; Vermeulen PB; Pawinski A; Prové A; Benoy I; De Pooter C; Martin M; Van Oosterom AT
    Br J Cancer; 1997; 76(2):238-43. PubMed ID: 9231925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.